Mild asthma is not mild: risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma.

There is a necessity to improve asthma patient categorization and redefine mild asthma's concept to heighten patient and physician attention. Identifying mild asthma patients that are highly vulnerable to severe acute exacerbations and researching the mechanisms are future prioritizations.